Journal
JOURNAL OF INFLAMMATION RESEARCH
Volume 15, Issue -, Pages 5373-5385Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/JIR.S380686
Keywords
TYK2; psoriasis; Janus kinase-signal transducer and activator of transcription; autoimmunity; inhibition
Categories
Ask authors/readers for more resources
This article reviews the pro-inflammatory mechanisms of the JAK-STAT signaling pathway, the regulatory roles of TYK2 in the pathogenesis of psoriasis, and provides updates on ongoing and recently completed clinical trials of TYK2 inhibitors.
Tyrosine kinase 2 (TYK2), a key part of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway, plays an integral role in the differentiation and immune responses of intrinsic immune cells and regulates the mediation of cytokines. TYK2 leads to inflammatory cascade responses in the pathogenesis of immune-mediated inflammatory diseases (IMIDs), especially psoriasis. Small-molecule TYK2 inhibitors are considered to be an effective strategy for modulating psoriasis. Here, we attempt to review the pro-inflammatory mechanisms of the JAK-STAT signaling pathway, the regulatory roles of TYK2 in the pathogenesis of psoriasis, and provide updates on ongoing and recently completed trials of TYK2 inhibitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available